PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,687,000 | +128.0% | 70,000 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $740,000 | +134.9% | 70,000 | 0.0% | 0.00% | – |
| Q3 2022 | $315,000 | +12.5% | 70,000 | 0.0% | 0.00% | – |
| Q2 2022 | $280,000 | -45.3% | 70,000 | 0.0% | 0.00% | – |
| Q1 2022 | $512,000 | +30.3% | 70,000 | 0.0% | 0.00% | – |
| Q4 2021 | $393,000 | -12.3% | 70,000 | 0.0% | 0.00% | – |
| Q3 2021 | $448,000 | -24.1% | 70,000 | 0.0% | 0.00% | – |
| Q2 2021 | $590,000 | -19.7% | 70,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $735,000 | -38.0% | 70,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,186,000 | +32.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $898,000 | -9.1% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $988,000 | +39.9% | 70,000 | -8.8% | 0.00% | +100.0% |
| Q1 2020 | $706,000 | -32.3% | 76,725 | +9.6% | 0.00% | 0.0% |
| Q4 2019 | $1,043,000 | +118.2% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $478,000 | -81.2% | 70,000 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $2,541,000 | – | 210,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |